Found 9 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer
PHASE2This study is conducting an evaluation of two chemotherapy drugs, Velcade a...
Location
Women & Infants' Hospital
Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
PHASE2This randomized phase II trial is studying bortezomib and irinotecan to see...
Location
Eastern Cooperative Oncology Group
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma
PHASE1This Phase One pediatric trial seeks to take advantage of the susceptibilit...
Location
The University of Michigan Comprehensive Cancer Center
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
PHASE1This is an single-center, prospective, open-label clinical trial, to explor...
Location
First Affiliated Hospital of Zhejiang University Schlool of Medicine
Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma
PHASE2The purpose of this study is to evaluate how tumors in patients with colore...
Location
Cooper Green Hospital / Jefferson Clinic P.C.
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
PHASE2This phase II trial is studying how well bortezomib with or without irinote...
Location
Montefiore Medical Center
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
PHASE1A Randomized, Double-Blind, Placebo-Controlled, Parallel, Multi-Center Stud...
Location
Southwest Cancer Center